Chakramarda: Traditional Uses, Evidence & Safety

TL;DR

Chakramarda (Cassia tora) seed is traditionally used in Ayurveda for ringworm and skin diseases, and as a laxative. Human evidence is thin: one small open trial in dadru (tinea) with 80 enrolled and 70 completing, plus one tiny combination-product lipid trial: both with major limitations. Most pharmacology is preclinical, no standalone dose is established, and long-term safety is unstudied.

What it is

Chakramarda is the dried seed of Cassia tora L. (syn. Senna tora), an annual herb of the Fabaceae family that grows wild in wastelands across India; the leaves and roots are also used medicinally (JETIR review; IJRPR study). Its Sanskrit synonyms Dadrughna and Dadamari are traditional glosses referring to its use against dadru (ringworm-type lesions) (IJRPR). The seeds are rich in anthraquinone compounds, including chrysophanic acid-9-anthrone, which laboratory work found active against ringworm fungi, while the leaves have a reported purgative action (JETIR review).

Traditional use

Ayurvedic texts value chakramarda above all for skin disease: kushta (chronic skin disorders), dadru (ringworm-type lesions), and kandu (itching). The seed paste is applied externally and the seeds are also taken internally as a blood-purifier for skin complaints. A paste of the root with lime juice is a traditional specific for ringworm, and the leaves are used as a purgative and applied pounded fresh to eczema (JETIR review). Classical energetics describe it as pungent (katu) in taste and post-digestive effect, hot (ushna) in potency, light and dry in quality, pacifying kapha and vata (IJRPR). These are traditional claims, not clinical proof: the human-trial evidence is assessed separately below.

What modern research says

Dadru / tinea (randomized trial)

An open randomized controlled group trial (80 enrolled, 70 completed) at the National Institute of Ayurveda, Jaipur, tested Cakramarda bija churna (seed powder) taken internally together with Edagajadi lepa applied topically with kanji, against the topical preparation alone, in dadru kushta (IJAPR). Both groups improved on itching, spreading of lesions, and redness, and the authors concluded both approaches were effective. Limitations: open-label with no placebo, and the seed powder was only tested in combination with the topical therapy: so the trial cannot isolate chakramarda's own effect.

Blood lipids (small RCT, combination product)

A 2005 randomized, double-blind, placebo-controlled trial (n=15) in Korean type 2 diabetics tested a fiber supplement containing 2 g of soluble fiber from Cassia semen plus vitamins E and C, two packs daily for 2 months (PubMed). Total cholesterol and the apolipoprotein B/A1 ratio fell modestly (P<.1); triglycerides and LDL tended downward; fasting glucose and HbA1c were unchanged; the authors reported no serious adverse effects. A tiny sample testing a combination product: a weak signal, not proof of a lipid-lowering effect.

Preclinical work

Laboratory studies report antifungal activity (chrysophanic acid-9-anthrone from seeds active against ringworm fungi; leaf extract against Microsporum nanum), alongside antioxidant, hepatoprotective, and anti-inflammatory signals in animal models (JETIR review). All preclinical: none of it is human proof.

Dosage

No dose of chakramarda is established in a pharmacopoeia or in a trial that tested the seed alone. The dadru trial used seed powder internally alongside topical therapy, and the lipid trial used a combination fiber product: neither yields a standalone dose.

Safety & contraindications

The small lipid trial's authors reported no serious adverse effects; the dadru trial report did not describe adverse events. Long-term safety in humans is unstudied. The leaves have a reported purgative action (JETIR review); do not use chakramarda as a long-term do-it-yourself laxative without medical supervision. Skin infections should be diagnosed by a clinician: traditional use is not a substitute for diagnosis. Safety in pregnancy and breastfeeding has not been studied.

FAQs

What is chakramarda used for in Ayurveda?

Primarily skin diseases, especially dadru (ringworm-type lesions), itching, and chronic skin disorders, with the seed used both externally and internally; the leaves are also used traditionally as a laxative (JETIR review).

Is there proof it works for ringworm?

Only weakly. One open randomized trial (80 enrolled, 70 completed) found improvement in dadru, but the seed powder was tested only in combination with a topical therapy and there was no placebo group, so chakramarda's own contribution is unproven (IJAPR). Laboratory studies show antifungal activity, but that is not human proof.

Can chakramarda lower cholesterol?

One tiny (n=15) combination-product trial showed a modest lipid signal with no serious adverse effects, but fasting glucose and HbA1c did not change (PubMed). Far too weak to support a cholesterol claim.

Is chakramarda safe?

The small lipid trial reported no serious adverse effects; the dadru trial report did not describe adverse events. Long-term human safety is unstudied, and safety in pregnancy and breastfeeding is unknown. Do not use it as an unsupervised long-term laxative.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.